Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Christine Ocampo

Affiliations

  • Pfao;cao/urovant Sciences, Inc at Urovant Sciences Ltd. (UROV), 2019-01-08
  • See Remarks at Novus Therapeutics Inc. (NVUS), 2017-05-26
  • Vice President, Finance at Avanir Pharmaceuticals Inc. (AVNR), 2014-12-19
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
NVUS $9.99 10,010 Officer 21,590 2017-05-10 Filing
AVNR $2.60 3,000 Officer 3,000 2012-03-06 Filing
AVNR $0.44 10,900 Officer 69,400 2009-02-24 Filing
AVNR $0.42 1,000 Officer 58,500 2009-02-24 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
AVNR $16.93 5,780 Officer 108,797 2014-12-18 Filing
AVNR $16.94 17,500 Officer 114,577 2014-12-16 Filing
AVNR $16.94 12,500 Officer 132,077 2014-12-16 Filing
AVNR $11.81 2,080 Officer 77,791 2014-10-24 Filing
AVNR $9.45 55,000 Officer 79,871 2014-09-15 Filing